Fernando Franco

5PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 21, 2022
Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study.

Ismael Fernández-Miranda, Lucía Pedrosa, Marta Llanos

|May 16, 2022
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

|Dec 13, 2021
Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data.

Virginia Calvo, Marta Andrés Fernández, Ana Collazo-Lorduy

|Jul 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.

Raquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal

|Aug 29, 2020
Clinical outcomes of FOLFIRINOX and gemcitabine-nab paclitaxel for metastatic pancreatic cancer in the real world setting.

F Franco, J C Camara, J I Martín-Valadés

Pageof 1

Frequent Collaborators

3 joint publications

Mariano Provencio

2 joint publications

Ernest Nadal

2 joint publications

Marta Casarrubios

2 joint publications

Alex Martínez-Martí